SCHEMBL30603045

SCHEMBL30603045

FC(F)(F)c1ccc(-c2cnc(Cl)c3nccnc23)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP1 P11387 3/20 0.44
KIF11 P52732 2/20 0.43
DYRK1A Q13627 1/20 0.41
DYRK2 Q92630 1/20 0.41
GABBR2 O75899 5/20 0.39
GABBR1 Q9UBS5 5/20 0.39
S1PR1 P21453 1/20 0.39
S1PR3 Q99500 1/20 0.39
ENPP1 P22413 1/20 0.38
CCNB2 O95067 1/20 0.38
CDK1 P06493 1/20 0.38
CCNB1 P14635 1/20 0.38
GSK3A P49840 1/20 0.38
GSK3B P49841 1/20 0.38
CCNB3 Q8WWL7 1/20 0.38
TOP2A P11388 1/20 0.38
SLC22A12 Q96S37 1/20 0.37
CYP19A1 P11511 1/20 0.36
KDM1A O60341 1/20 0.35
MAOB P27338 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30603042 1.00 TOP1 (0.44) TOP1KIF11DYRK1ADYRK2GABBR2
SCHEMBL26614921 1.00 TOP1 (0.44) TOP1KIF11DYRK1ADYRK2GABBR2
SCHEMBL26615070 0.92 TOP1 (0.39) TOP1KIF11DYRK1ADYRK2GABBR2
SCHEMBL30602981 0.82 TOP1 (0.50) TOP1KIF11ENPP1TOP2A
SCHEMBL26614885 0.82 TOP1 (0.50) TOP1KIF11ENPP1TOP2A
SCHEMBL26627709 0.73 TOP1 (0.39) TOP1KIF11DYRK1AGABBR2GABBR1
Hydrochloric Acid SCHEMBL26627622 0.72 TOP1 (0.38) TOP1KIF11DYRK1AGABBR2GABBR1
SCHEMBL24393267 0.71 MAP4K4 (0.44) TOP1KIF11DYRK1ADYRK2S1PR1
SCHEMBL3322318 0.70 KIF11 (0.50) KIF11DYRK1ADYRK2S1PR1S1PR3
SCHEMBL23796227 0.70 TRPV1 (0.43) TOP1KIF11DYRK1ADYRK2S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023209090-A1 BICYCLIC HETEROAROMATIC COMPOUNDS AND THEIR APPLICATION IN THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2023-11-02 WO disclosed